Incyte stock slammed after study fails to hit goal

Incyte stock slammed after study fails to hit goal

Source: 
Marketwatch
snippet: 

Incyte Corp. INCY, -1.55% shares fell more than 12% in after-hours trading Thursday after the company revealed that a phase-3 study of a drug failed to reach its goal.